Aker BioMarine

Lysaker, Norway Founded: 2002 • Age: 24 yrs Listed Acquired By American Industrial Partners
Aker BioMarine is recognized as a leading supplier of krill-based nutritional ingredients.

About Aker BioMarine

Aker BioMarine is a publicly listed company based in Lysaker (Norway) founded in 2002, and was acquired by American Industrial Partners in July 2024. Aker BioMarine is recognized as a leading supplier of krill-based nutritional ingredients. It operates on a Direct-to-Consumer (D2C) and B2B2C model. The company has 249 employees. Its chief executive is Matts Johansen. Its website akerbiomarine.com draws about 14 thousand monthly visits. Its Indian entity Qrill Feeds India Private Limited reported revenue of β‚Ή102 Cr. Aker BioMarine offers products and services including Krill Oil and Consumer Health Products. Its focus areas include Biotechnology and Nutritional Supplements. Its competitors include Advanced Enzyme Technologies, The DuPont Nutrition and Health, Enzymotec, Zivo Bioscience and Kaffe Bueno and 4 more; 6 of its 9 listed competitors have raised funding.

Company details

Aker BioMarine is established as a prominent provider of natural krill ingredients for human health and nutrition. The company is focused on the biotechnology sector, specializing in krill oil and related consumer health products. Solutions are developed for improving omega-3 deficiency and overall wellness. Operations are centered in the healthcare and nutritional supplements industry, with an emphasis on sustainability and traceability. Research and innovation are prioritized to enhance product efficacy and environmental impact.

  • Headquarters Lysaker, Norway
  • Employees 249
  • Stage Acquired
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website akerbiomarine.com
  • Social LinkedIn X Facebook Instagram
  • Acquired by Lindsay Goldberg (Sep 2010)
  • Legal Name Aker Biomarine Asa
Key Metrics

Products & Services of Aker BioMarine

Aker BioMarine offers a comprehensive portfolio of products and services, including Krill Oil and Consumer Health Products.

Krill Oil
Human Health Ingredients

Krill oil is provided for human nutritional benefits.

Consumer Health Products
Consumer Health

Consumer health products are offered for general wellness.

Funding Insights of Aker BioMarine

  • Total Rounds 1

All 1 funding rounds of Aker BioMarine with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Jun 2020–Post-IPO––
–
Valuation history

2 investors in total: 2 institutional.

Investors in Aker BioMarine

Aker BioMarine has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include American Industrial Partners and Lindsay Goldberg.

All
Venture Fund
InvestorDescriptionFounded YearDomainLocation
Control investments are made in middle-market industrial businesses.
–americanindustrial.comNew York, United States
PE firm invests in the US
–lindsaygoldbergllc.comNew York, United States
Premium access

Investor details for Aker BioMarine

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Board of directors of Qrill Feeds India Private Limited (Aker BioMarine)

Qrill Feeds India Private Limited is the primary company behind Aker BioMarine. The board of Qrill Feeds India Private Limited currently have 2 directors; the longest-serving is Sigve Nordrum, appointed in 2018.

DirectorDesignationAppointedTenureEntity
Sigve Nordrum
DIN 08249167
Director04 Oct 20188 yrsQrill Feeds India Private Limited
Atul Kumar Barman
DIN 00944548
Director04 Oct 20188 yrsQrill Feeds India Private Limited

People of Aker BioMarine

38 people are tracked at Aker BioMarine (22 in leadership, 5 in board & advisors, 11 in team); the tracked headcount is 249.

NameRoleGroup
Matts Johansen
CEOLeadership
Cashtyn Lovan
Director Of Marketing And Business DevelopmentLeadership
Lotte Skolem
VP GrowthLeadership
Hege Spaun
Chief People & External Affairs OfficerLeadership
Katrine Klaveness
CFOLeadership
Lars Jacobsen
General Counsel And Chief Compliance OfficerLeadership
Tone Lorentzen
Chief Operating Officer, Human Health IngredientLeadership
Marte Dalsegg
Executive Vice President People And CommunicationsLeadership
Jaroslava Olsen
Chief Marketing OfficerLeadership
Hanne Bache
Director People, Organization & CultureLeadership
Yunpeng Ding
Director R&d, Human NutritionLeadership
Anniken Nordby Færgestad
VP FinanceLeadership
Benedicte Gehrken-Lindboe
Director Financial Reporting And ComplianceLeadership
Kees van de Watering
VP Process Engineering - Protein Human NutritionLeadership
Gian Franco Guerrieri
Sales Director Human Nutrition – Latin AmericaLeadership
Kiranpreet Kaur
Director R&d, AquacultureLeadership
Øyvind Våge
Head Of Operations, Protein Human NutritionLeadership
Christopher Robin Vinter
VP Strategic Finance & IRLeadership
Eirik Vasstein
Chief EngineerLeadership
Louie Skjong
Chief EngineerLeadership

18 more people are available in the full profile.

Premium access

Complete people profiles for Aker BioMarine

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

IPO & Listings of Aker BioMarine

Aker BioMarine is a publicly listed company on the OSL with ticker symbol AKBM in Norway, operating in the Process industries sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.

  • IPO date23 Apr 2021
  • Listed onFRA: 1PG
  • Listed entityAker BioMarine ASA
  • Exchange sectorProcess industries
  • ISINNO0010886625
  • Share price101.80 NOK (-1.17% on the day) · 2026-05-11
  • Market capitalisation9,035,523,178.00 NOK
  • EPS (diluted, trailing year)-2.64 NOK
  • Volume (last session)4,983
  • Analyst consensusBuy

Financials of Aker BioMarine

Figures of Qrill Feeds India Private Limited, the primary company behind Aker BioMarine, for FY 2023. Revenue was ₹102 Cr (+4% year on year). Net profit was ₹7.60 Cr (7% margin). EBITDA was ₹10.21 Cr (10% margin). Revenue has grown at a compounded annual rate of +342% over three years.

  • ₹102 CrRevenue · FY 2023 · +4% YoY
  • ₹7.60 CrNet profit · 7% margin
  • ₹10.21 CrEBITDA · 10% margin
  • ₹1.50 CrPaid-up capital
  • 4Employees (provident fund records)
  • +342%Revenue CAGR, 3 years
Exchange-reported annual figures
YearRevenueNet incomeEBITDA
20242.14B NOK-309.7M NOK182.8M NOK
20232.07B NOK-95.1M NOK173.4M NOK
20222.67B NOK96.2M NOK618.6M NOK
20212.25B NOK-68.9M NOK378.4M NOK
20202.72B NOK-51.4M NOK700.5M NOK

Balance sheet, profit and loss, cash flow and ratios of Qrill Feeds India Private Limited are on its company page.

Premium access

Detailed financial statements for Aker BioMarine

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Timeline of Aker BioMarine

5 dated milestones of Aker BioMarine across 22 years, from founding to its latest funding, stage changes and deals.

  1. Founded Aker BioMarine is founded.
  2. Exit Acquired by Lindsay Goldberg.
  3. Funding First funding round.
  4. IPO Lists on the stock exchange (IPO).
  5. Exit Acquired by American Industrial Partners.

Competitors of Aker BioMarine

Aker BioMarine has 9 listed competitors in our database, 6 of them funded. They include Advanced Enzyme Technologies, The DuPont Nutrition and Health, Enzymotec, Zivo Bioscience and Kaffe Bueno, among others.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
advancedenzymes.com1989Thane, India–689
Enzymes are manufactured for nutrition, food, feed, and textile industries.
danisco.com1989Copenhagen, Denmark$880,0851,007
Manufactures a range of health ingredients
enzymotec.com1998Kfar Saba, Israel$21M–
Bio-functional lipid ingredients are developed for nutritional and pharmaceutical uses.
zivobioscience.com1983Keego Harbor, United States$962,00010
Bioactive compounds from algal strain
kaffebueno.com2016Copenhagen, Denmark$8.13M–
Coffee beans are supplied by Kaffe Bueno in multiple categories.
zarbees.com2008Draper, United States$28.28M–
Natural cough remedies and wellness products are developed by Zarbees.
interhealthusa.com1987Benicia, United States–33
Nutraceutical and specialty ingredients are researched, developed, and supplied.
nexira.com1895Rouen, France––
Natural ingredients are manufactured for food, health, and nutrition sectors.
maolac.com2020Jerusalem, Israel$3.2M–
Developing antibodies and nutrients enriched preventive nutritional products.
Premium access

Detailed competitors of Aker BioMarine

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of Aker BioMarine

The website of Aker BioMarine (akerbiomarine.com) receives about 14.5K visits a month.

  • Monthly visits
    14.5K

    ▲ 0.6% vs previous month

Similar websites

Websites whose visitors overlap most with Aker BioMarine. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
nutraceuticalbusinessreview.com
100%
–#712,967View details
champion-bio.com
champion-bio.com
78%
–#2,414,056–
sunsho.co.jp
63%
39.7K#754,747View details
omegaquant.com
60%
84.6K#552,920View details
nutraingredients-usa.com
60%
–#11,120,428View details
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
Premium access

All 6 similar websites and full traffic analytics for Aker BioMarine

The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.

  • 6 similar websites
  • Audience overlap
  • Engagement analytics
  • Traffic by brand

Verified entity values are shown only after access is granted.

Top companies in Nutraceutical & Food-as-Medicine Platforms

10 companies that operate in the same segment as Aker BioMarine (Nutraceutical & Food-as-Medicine Platforms), ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Ayurvedic healthcare and nutritional products are provided by Kapiva.
2016Bengaluru, Karnataka, IndiaUSD 77.85 MUSD 27.35 M362
Plant-based frozen meals are delivered via weekly subscriptions.
2016London, England, United KingdomUSD 69.9 MUSD 12.54 M146
Therapies for metabolic health in chronic disease patients are provided.
2014San Francisco, California, United StatesUSD 401.78 M–910
Nutritional supplements for multiple health ailments are developed.
2005Mumbai, Maharashtra, IndiaUSD 1.55 M––
Personalized gut health solutions are provided by ZOE.
2017New Castle, Pennsylvania, United StatesUSD 15 M––
Machine learning-based bioinformatics solutions for health insights are provided.
2016Los Alamos, New Mexico, United StatesUSD 301.57 M––
Cellular health supplements for metabolic repair are developed and manufactured.
2014New York, New York, United StatesUSD 66.1 M––
Nutritional food and health supplements are provided by OZiva.
2010Mumbai, Maharashtra, IndiaUSD 17.32 MUSD 23.98 M–
Low-carb products for weight loss are provided by Atkins.
1960Denver, Colorado, United StatesUSD 15 M––
Synbiotic supplements and fermented products for gut health are provided.
2021Mumbai, Maharashtra, IndiaUSD 20.02 MUSD 5.14 M88
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Aker Biomarine

Premium access

Complete news archive for Aker BioMarine

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Aker BioMarine

Aker BioMarine was founded in 2002 and raised its 1st funding round 18 years after it was founded.

Aker BioMarine is headquartered in Lysaker, Norway.

Matts Johansen is the current CEO of Aker BioMarine.

Aker BioMarine has 249 employees.

The primary company behind Aker BioMarine, Qrill Feeds India Private Limited, reported revenue of β‚Ή102 Cr for FY 2023, up 4% year on year.

Aker BioMarine is established as a prominent provider of natural krill ingredients for human health and nutrition. The company is focused on the biotechnology sector, specializing in krill oil and related consumer health products. Solutions are developed for improving omega-3 deficiency and overall wellness. Operations are centered in the healthcare and nutritional supplements industry, with an emphasis on sustainability and traceability. Research and innovation are prioritized to enhance product efficacy and environmental impact.

Aker BioMarine's top competitors include Advanced Enzyme Technologies, Zivo Bioscience and Enzymotec.

Aker BioMarine offers Krill Oil and Consumer Health Products.

Yes, Aker BioMarine is publicly traded on OSL under the ticker symbol AKBM.

Aker BioMarine has 2 investors. Key investors include American Industrial Partners, and Lindsay Goldberg.

Aker BioMarine operates through Qrill Feeds India Private Limited.

Yes. Aker BioMarine was acquired by Lindsay Goldberg in September 2010.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available